CS

Camille Samuels

24+ years(!) in life sciences venture capital at Venrock and Versant. Busy on my boards while exploring starting a company focused on complex diseases

Menlo Park, California

VC
Investor

Invests in

  • Min Investment:

    $2,000,000.00

  • Max Investment:

    $40,000,000.00

  • Target Investment:

    $10,000,000.00

Skills

Venture Capital
Corporate Development
Due Diligence
Start-ups
Mergers
Entrepreneurship
Corporate Finance
Business Strategy
Biotechnology
Valuation
Strategy
Commercialization
Business Development
Private Equity
Mergers & Acquisitions
Technology Transfer
Financial Modeling
Executive Management
Pharmaceutical Industry
Life Sciences

Education

Lists including Camille

AT
AS
AT
AH

All Series A Investors

14748 people

Investments

Ocelot Bio

Series A

Total Funding: $36M

UNITY Biotechnology

Series A

Total Funding: $210M

Spirox

Series B

Total Funding: $64M

REGENXBIO

Series C

Total Funding: $100M

Carmenta Bioscience

Seed

Total Funding: $2M

Achaogen

Series B

Total Funding: $120M

Kythera Biopharmaceuticals

Seed

Total Funding: $98M

Work Experience

Various Boards

2025

  • Director

    2025

    Deeply experienced at supporting, building, and financing life sciences companies. Invested in providing treatments for diseases that have none -- all while enjoying/prodding/helping the wonderful people of biopharma

V
Venrock

2014 - 2025

  • Partner

    2014 - 2025

VV
Versant Ventures

2000 - 2012

  • Managing Director

    2000 - 2012

Tularik

1998 - 2000

  • Director of Business Development

    1998 - 2000

LC
L.E.K. Consulting

1993 - 1996

  • Associate Consultant

    1993 - 1996